Cargando…
Prevalance of abnormal vault cytology after hysterectomy for cervical intraepithelial neoplasia, Pietermaritzburg
BACKGROUND: A simple hysterectomy is considered the definitive treatment modality for cervical intraepithelial neoplasia (CIN). However, it is associated with recurrence of vaginal intraepithelial neoplasia (VAIN) of up to 7.4%. We sought to determine recurrence rates of VAIN, in women living with H...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AOSIS
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8991234/ https://www.ncbi.nlm.nih.gov/pubmed/35384680 http://dx.doi.org/10.4102/safp.v64i1.5457 |
_version_ | 1784683535458631680 |
---|---|
author | Mbuyisa, Sanele S. Khumalo, Thandekile L. Makhathini, Bongumusa S. Moodley, Jagidesa |
author_facet | Mbuyisa, Sanele S. Khumalo, Thandekile L. Makhathini, Bongumusa S. Moodley, Jagidesa |
author_sort | Mbuyisa, Sanele S. |
collection | PubMed |
description | BACKGROUND: A simple hysterectomy is considered the definitive treatment modality for cervical intraepithelial neoplasia (CIN). However, it is associated with recurrence of vaginal intraepithelial neoplasia (VAIN) of up to 7.4%. We sought to determine recurrence rates of VAIN, in women living with HIV (WLWH) and non-infected women. METHODS: This was a descriptive retrospective review of patients who received a simple hysterectomy for CIN between January 2015 and December 2017 in Pietermaritzburg. RESULTS: Fifty-eight files were reviewed. Forty-two (72.4%) WLWH were seen; amongst those, 76.2% were virally suppressed. Abnormal vault cytology was only seen in patients with CIN grades 2 and 3. The recurrence rates for high-grade squamous intraepithelial lesion (HSIL) were 6.1% and 5.0% at 6 and 12 months, respectively. Human immunodeficiency virus co-infection was associated with 26.2% versus 13.3% of abnormal vault cytology compared to the HIV-negative counterparts (p = 0.164). Virologically suppressed patients had more abnormal cytology (28.1% vs. 0%) compared to the unsuppressed patients. There was a 17.2% and 65.5% loss- to follow-up rates at 6 and 12 months, respectively. Recurrence of premalignant lesions was noted amongst those who had the abdominal approach. CONCLUSION: The recurrence rates were comparable to the previous literature. A 6-month cytology follow-up showed no added benefit. Human immunodeficiency virus co-infection didn’t show a statistical significance on the recurrence rates; however, more structured studies are required to address this. Primary health care-based post operative surveillance can be a solution to address high loss to follow-up. |
format | Online Article Text |
id | pubmed-8991234 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | AOSIS |
record_format | MEDLINE/PubMed |
spelling | pubmed-89912342022-04-09 Prevalance of abnormal vault cytology after hysterectomy for cervical intraepithelial neoplasia, Pietermaritzburg Mbuyisa, Sanele S. Khumalo, Thandekile L. Makhathini, Bongumusa S. Moodley, Jagidesa S Afr Fam Pract (2004) Original Research BACKGROUND: A simple hysterectomy is considered the definitive treatment modality for cervical intraepithelial neoplasia (CIN). However, it is associated with recurrence of vaginal intraepithelial neoplasia (VAIN) of up to 7.4%. We sought to determine recurrence rates of VAIN, in women living with HIV (WLWH) and non-infected women. METHODS: This was a descriptive retrospective review of patients who received a simple hysterectomy for CIN between January 2015 and December 2017 in Pietermaritzburg. RESULTS: Fifty-eight files were reviewed. Forty-two (72.4%) WLWH were seen; amongst those, 76.2% were virally suppressed. Abnormal vault cytology was only seen in patients with CIN grades 2 and 3. The recurrence rates for high-grade squamous intraepithelial lesion (HSIL) were 6.1% and 5.0% at 6 and 12 months, respectively. Human immunodeficiency virus co-infection was associated with 26.2% versus 13.3% of abnormal vault cytology compared to the HIV-negative counterparts (p = 0.164). Virologically suppressed patients had more abnormal cytology (28.1% vs. 0%) compared to the unsuppressed patients. There was a 17.2% and 65.5% loss- to follow-up rates at 6 and 12 months, respectively. Recurrence of premalignant lesions was noted amongst those who had the abdominal approach. CONCLUSION: The recurrence rates were comparable to the previous literature. A 6-month cytology follow-up showed no added benefit. Human immunodeficiency virus co-infection didn’t show a statistical significance on the recurrence rates; however, more structured studies are required to address this. Primary health care-based post operative surveillance can be a solution to address high loss to follow-up. AOSIS 2022-03-31 /pmc/articles/PMC8991234/ /pubmed/35384680 http://dx.doi.org/10.4102/safp.v64i1.5457 Text en © 2022. The Authors https://creativecommons.org/licenses/by/4.0/Licensee: AOSIS. This work is licensed under the Creative Commons Attribution License. |
spellingShingle | Original Research Mbuyisa, Sanele S. Khumalo, Thandekile L. Makhathini, Bongumusa S. Moodley, Jagidesa Prevalance of abnormal vault cytology after hysterectomy for cervical intraepithelial neoplasia, Pietermaritzburg |
title | Prevalance of abnormal vault cytology after hysterectomy for cervical intraepithelial neoplasia, Pietermaritzburg |
title_full | Prevalance of abnormal vault cytology after hysterectomy for cervical intraepithelial neoplasia, Pietermaritzburg |
title_fullStr | Prevalance of abnormal vault cytology after hysterectomy for cervical intraepithelial neoplasia, Pietermaritzburg |
title_full_unstemmed | Prevalance of abnormal vault cytology after hysterectomy for cervical intraepithelial neoplasia, Pietermaritzburg |
title_short | Prevalance of abnormal vault cytology after hysterectomy for cervical intraepithelial neoplasia, Pietermaritzburg |
title_sort | prevalance of abnormal vault cytology after hysterectomy for cervical intraepithelial neoplasia, pietermaritzburg |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8991234/ https://www.ncbi.nlm.nih.gov/pubmed/35384680 http://dx.doi.org/10.4102/safp.v64i1.5457 |
work_keys_str_mv | AT mbuyisasaneles prevalanceofabnormalvaultcytologyafterhysterectomyforcervicalintraepithelialneoplasiapietermaritzburg AT khumalothandekilel prevalanceofabnormalvaultcytologyafterhysterectomyforcervicalintraepithelialneoplasiapietermaritzburg AT makhathinibongumusas prevalanceofabnormalvaultcytologyafterhysterectomyforcervicalintraepithelialneoplasiapietermaritzburg AT moodleyjagidesa prevalanceofabnormalvaultcytologyafterhysterectomyforcervicalintraepithelialneoplasiapietermaritzburg |